Browse > Article

Functional Expression of Saccharomyces cerevisiae NADH-quinone Oxidoreductase (NDI1) Gene in the AML12 Mouse Liver Hepatocytes for the Applying Embryonic Stem Cell  

Seo, Byoung-Boo (Dept. of Animal Resources, College of Life & Environmental Science, Daegu University)
Park, Hum-Dai (Dept. of Biotechnology, College of Engineering, Daegu University)
Publication Information
Abstract
Mitochondria diseases have been reported to involve structural and functional defects of complex I-V. Especially, many of these diseases are known to be related to dysfunction of mitochondrial proton-translocating NADH-ubiquinone oxidoreductase (complex I). The dysfunction of mitochondria complex I is associated with neurodegenerative disorders, such as Parkinson's disease, Huntington's disease, and Leber's hereditary optic neuropathy (LHON). Mammalian mitochondrial proton-translocating NADH-quinone oxidoreductase (complex I) is largest and consists of at least 46 different subunits. In contrast, the NDI1 gene of Saccharomyces cerevisiae is a single subunit rotenone-insensitive NADH-quinone oxidoreductase that is located on the matrix side of the inner mitochondrial membrane. The Saccharomyces cerevisiae NDI1 gene using a recombinant adeno-associated virus vector (rAAV-NDI1) was successfully expressed in AML12 mouse liver hepatocytes and the NDI1-transduced cells were able to grow in media containing rotenone. In contrast, control cells that did not receive the NDI1 gene failed to survive. The expressed Ndi1 enzyme was recognized to be localized in mitochondria by confocal immunofluorescence microscopic analyses and immunoblotting. Using digitonin-permeabilized cells, it was shown that the NADH oxidase activity of the NDI1-transduced cells was not affected by rotenone which is inhibitor of complex I, but was inhibited by antimycin A. Furthermore, these results indicate that Ndi1 can be functionally expressed in the AML12 mouse liver hepatocytes. It is conceivable that the NDI1 gene is powerful tool for gene therapy of mitochondrial diseases caused by complex I deficiency. In the future, we will attempt to functionally express the NDI1 gene in mouse embryonic stem (mES) cell.
Keywords
NDI1 gene; AML12 mouse liver hepatocytes; Gene therapy; Mouse embryonic stem cell;
Citations & Related Records
연도 인용수 순위
  • Reference
1 de Vries S, Grivell LA (1988): Purification and characterization of a rotenone-insensitive NADH-Q6 oxidoreductase from mitochondria of Saccharomyces cerevisiae. Eur J Biochem 176:377-384.   DOI   ScienceOn
2 Sherer TB, Betarbet R, Greenamyre JT (2002): Environment, mitochondria, and Parkinson's disease. Neuroscientist 8:192-197.
3 de Vries S, Van Witzenburg R, Grivell LA, Marres CAM (1992): Primary structure and import pathway of the rotenone-insensitive NADH-ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae. Eur J Biochem 203:587-592.   DOI   ScienceOn
4 Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Guggino WB, Carter BJ (1993): Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 90:10613-10617.   DOI   ScienceOn
5 Granger DL, Lehninger AL (1982): Sites of inhibition of mitochondrial electron transport in macrophage- injured neoplastic cells. J Cell Biol 95: 527- 535.   DOI   ScienceOn
6 Guy J, Qi X, Pallotti F, Schon EA, Manfredi G, Carelli V, Martinuzzi A, Hauswirth WW, Lewin AS (2002): Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy. Ann Neurol 52: 534-542.   DOI   ScienceOn
7 Hatefi Y (1985): The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 54:1015-1069.   DOI   ScienceOn
8 Hofhaus G, Shakeley RM, Attardi G (1996): Use of polarography to detect respiration defects in cell cultures. Methods Enzymol 264:476-483.
9 Kitajima-Ihara T, Yagi T (1998): Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria: the enzyme expressed in Escherichia coli acts as a member of the respiratory chain in the host cells. FEBS Lett 421:37-40.   DOI   ScienceOn
10 Klimatcheva E, Rosenblatt JD, Planelles V (1999): Lentiviral vectors and gene therapy. Front Biosci 4:D- 481-D496.   DOI
11 Laemmli UK (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.   DOI   ScienceOn
12 Luft R (1994): The development of mitochondrial medicine. Proc Natl Acad Sci USA 91(19):8731-8.   DOI   ScienceOn
13 Seo BB, Wang J, Flotte TR, Yagi T, Matsuno-Yagi A (2000): Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells. J Biol Chem 275:37774-37778.   DOI
14 Shoffner JM, Wallace DC (1994): Oxidative phosphorylation diseases and mitochondrial DNA mutations diagnosis and treatment. Rev Nutr 14:535-568.   DOI
15 Seo BB, Kitajima-Ihara T, Chan EK, Scheffler IE, Matsuno- Yagi A, Yagi T (1998): Molecular remedy of complex I defects: Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proc Natl Acad Sci USA 95:9167-9171.   DOI   ScienceOn
16 Seo BB, Matsuno-Yagi A, Yagi T (1999): Modulation of oxidative phosphorylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae. Biochim Biophys Acta 1412:56-65.   DOI   ScienceOn
17 Singer DR, Sagnella GA, Markandu ND, Buckley MG, MacGregor GA (1987): Atrial natriuretic peptide, blood pressure, and age. Lancet 2:1394-1395.
18 Todd S, Anderson C, Jolly DJ, Craik CS (2000): HIV protease as a target for retrovirus vector-mediated gene therapy. Biochim Biophys Acta 1477:168-188.   DOI   ScienceOn
19 Trounce IA, Kim YL, Jun AS, Wallace DC (1996): Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Method Enzymol 264: 484-509.
20 Wallace DC (1992): Diseases of the mitochondrial DNA. Annu Rev Biochem 61:1175-1212.   DOI   ScienceOn
21 Wallace DC, Shoffner JM, Watts RL, Juncos JL, Torroni A (1992): Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 32: 113-114.   DOI   ScienceOn
22 Wallace DC (1993): Mitochondrial diseases: genotype versus phenotype. Trends Genet 9(4):128-33.   DOI   ScienceOn
23 Wu N, Ataai MM (2000): Production of viral vectors for gene therapy applications. Curr Opin Biotechnol 11:205-208.   DOI   ScienceOn
24 Burger C, Nash K, Mandel RJ (2005): Recombinant adeno-associated viral vectors in the nervous system. Hum Gene Ther 16(7):781-91.   DOI   ScienceOn
25 Au HC, Seo BB, Matsuno-Yagi A, Yagi T, Scheffler IE (1999): The NDUFA1 gene product (MWFE protein) is essential for activity of complex I in mammalian mitochondria. Proc Natl Acad Sci USA 96:4354-4359.   DOI   ScienceOn
26 Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000): Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306.   DOI   ScienceOn
27 Buchanan SK, Walker JE (1996): Large-scale chromatographic purification of F1F0-ATPase and complex I from bovine heart mitochondria. Biochem J 318:343- 349.   DOI
28 Chomyn A, Mariottini P, Cleeter MWJ, Ragan CI, Matsuno- Yagi A, Hatefi Y, Doolittle RF, Attardi G (1985): Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenase. Nature 314:591-597.
29 Chomyn A, Cleeter MWJ, Ragan CI, Riley M, Doolittle RF, Attardi G (1986): URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science 234:614-618.   DOI
30 Dawson TM, Dawson VL (2003): Molecular pathways of neurodegeneration in Parkinson's disease. Science 302:819-822.   DOI   ScienceOn
31 De Francesco L, Scheffler IE, Bissell M (1976): A respiration- deficient Chinese hamster cell line with a defect in NADH-coenzyme Q reductase. J Biol Chem 251: 4588-4595.
32 Marella M, Seo BB, Flotte TR, Matsuno-Yagi A, Yagi T (2011): No immune responses by the expression of the yeast ndi1 protein in rats. PLoS One 6(10):e25910   DOI
33 Manfredi G, Fu J, Ojaimi J, Sadlock JE, Kwong JQ, Guy J, Schon EA (2002): Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat Genet 30:394-399.   DOI   ScienceOn
34 Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002): The herbicide paraquat causes up-regulation and aggregation of $\alpha$-synuclein in mice: paraquat and $\alpha$-synuclein. J Biol Chem 277:1641-1644.   DOI
35 Marres CAM, de Vries S, Grivell LA (1991): Isolation and inactivation of the nuclear gene encoding the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of mitochondria from Saccharomyce cerevisiae. Eur J Biochem 195:857-862.   DOI   ScienceOn
36 Muzyczka N (1994): Adeno-associated virus (AAV) vectors: will they work? J Clin Invest 94:1351.   DOI   ScienceOn
37 Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996): In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.   DOI
38 Nesnow S, Grindstaff RD, Lambert G, Padgett WT, Bruno M, Ge Y, Chen PJ, Wood CE, Murphy L (2011): Propiconazole increases reactive oxygen species levels in mouse hepatic cells in culture and in mouse liver by a cytochrome P450 enzyme mediated process. Chem Biol Interact 194 (1):79-89.   DOI   ScienceOn
39 Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT (2003): Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 23:10756-10764.
40 Robbins PD, Ghivizzani SC (1998): Viral vectors for gene therapy. Pharmacol Ther 80:35-47.   DOI   ScienceOn
41 Yagi T (1993): The bacterial energy-transducing NADH- quinone oxidoreductases. Biochim Biophys Acta 1141:1-17.   DOI   ScienceOn